EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Comparative evaluation of the efficacy of leukocyte platelet-rich fibrin block and advanced platelet-rich fibrin combined with bone graft in treating infrabony defects

Purushottam Kumar, Ellora Madan, Sohini Chakraborty, Dharitri Sharma, Dikshita Medhi, Tanusmita Pathak

National Journal of Maxillofacial Surgery · 2026-01 · 17 (1) · 161-166

DOI: 10.4103/njms.njms_155_24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift National Journal of Maxillofacial Surgery, online erschienen am 30.04.2026. Verfasst von Purushottam Kumar und 5 weiteren Autor:innen. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The primary objective of periodontal therapy is to restore the compromised periodontium through regenerative processes. Platelet-rich fibrin (PRF) is a vital biomaterial in this context due to its rich concentration of growth factors within a fibrin matrix.

Aim

This study aimed to compare the efficacy of leukocyte-PRF block (L-PRF block) and advanced PRF (A-PRF) combined with bone graft (hydroxyapatite) in treating infrabony defects (IBDs). Materials and Methods: Forty sites with IBDs were randomly assigned to two groups: Group A received A-PRF with bone graft, and Group B received L-PRF block. Criteria for inclusion included probing pocket depth (PPD) ≥5 mm, clinical attachment loss (CAL) ≥3 mm, gingival index (GI) ≥1, and evidence of IBDs ≥ 3 mm observed via cone beam computed tomography. Measurements of GI, PPD, CAL, crestal level (CL), and bone fill were recorded at baseline, 3 months, and 6 months.

Results

Both groups showed significant reductions in GI at the 6-month mark ( P < 0.05). In Group A, PPD decreased from 6.850 ± 1.2258 (baseline) to 3.750 ± 0.9105 (6 months), and CAL decreased from 11.100 ± 1.8035 to 8.000 ± 2.2243. In Group B, PPD reduced from 7.500 ± 0.8885 to 3.250 ± 0.5501, and CAL reduced from 11.250 ± 1.5517 to 7.000 ± 1.7472 at 6 months. Intergroup comparisons showed a better outcome for PPD in Group A, while CAL differences were statistically non-significant. IBD measurements and bone fill comparisons between the groups were also non-significant.

Conclusion

In conclusion, both L-PRF block and A-PRF combined with bone graft showed significant improvements in assessed parameters over six months. However, there were no significant differences between the two groups, indicating both treatments are effective for addressing IBDs.

Zitieren

APA

Kumar, P., Madan, E., Chakraborty, S., Sharma, D., Medhi, D., & Pathak, T. (2026). Comparative evaluation of the efficacy of leukocyte platelet-rich fibrin block and advanced platelet-rich fibrin combined with bone graft in treating infrabony defects. National Journal of Maxillofacial Surgery, 17(1), 161-166. https://doi.org/10.4103/njms.njms_155_24

Vancouver

Kumar P, Madan E, Chakraborty S, Sharma D, Medhi D, Pathak T. Comparative evaluation of the efficacy of leukocyte platelet-rich fibrin block and advanced platelet-rich fibrin combined with bone graft in treating infrabony defects. National Journal of Maxillofacial Surgery. 2026;17(1):161-166. doi:10.4103/njms.njms_155_24

BibTeX
@article{Kumar2026,
  author = {Kumar, Purushottam and Madan, Ellora and Chakraborty, Sohini and Sharma, Dharitri and Medhi, Dikshita and Pathak, Tanusmita},
  title = {Comparative evaluation of the efficacy of leukocyte platelet-rich fibrin block and advanced platelet-rich fibrin combined with bone graft in treating infrabony defects},
  journal = {National Journal of Maxillofacial Surgery},
  year = {2026},
  volume = {17},
  number = {1},
  pages = {161--166},
  doi = {10.4103/njms.njms_155_24}
}
Kostenlos starten →